Skip to main content

Abstract

Objectives

Current protocols for processing multiple prostate biopsy cores per case are uneconomical and cumbersome. Tissue fragmentation and loss compromise cancer diagnosis. We sought to study an alternate method to improve the processing and diagnosis of prostate cancer.

Methods

Two sets of sextant biopsy specimens from near-identical locations were obtained ex vivo from 48 prostate specimens. One set was processed in the standard fashion, while the other was processed using the BxChip, a proprietary biomimetic matrix that accommodates six cores on a single chip. Parameters including grossing, embedding, sectioning and reading time, tissue length, and fragmentation degree were compared.

Results

A significant reduction (more than threefold) in preanalytical and analytical time was observed using the multiplex method. Nonlinear fragmentation was absent, in contrast to standard processing.

Conclusions

The BxChip reduced tissue fragmentation and increased the efficiency of prostate biopsy diagnosis. It also resulted in overall cost savings and significantly increased tissue length.

Download PDF

Read the study

American Journal of Clinical Pathology, Volume 152, Issue 6, December 2019, Pages 757–765, https://doi.org/10.1093/ajcp/aqz101

 

Leave a Reply